Code | 6170C | ||||||||||
MA number | EU/1/17/1238/001 | ||||||||||
Product Form: | aer nas 2x1,8 mg (liek.skl.) | ||||||||||
MA Status: | E - Valid centralised marketing authorisation | ||||||||||
Type of procedure: | EU | ||||||||||
MAH, country: | Mundipharma Corporation (Ireland) Limited, Ireland | ||||||||||
Therapeutic Class: | 19 - ANTIDOTA, DETOXICANTIA | ||||||||||
ATC: |
|
||||||||||
Shelf life: | 36 | ||||||||||
Container: | glass container | ||||||||||
Route of admin.: | Nasal use |
Prescription Status: | Medicinal product subject to medical prescription. |
Legal basis: | Article 10(3) hybrid application |
MA issued: | 10.11.2017 |
SmPC + PL: |
|
Safety feature | Yes |
Data update: | 04.10.2022 |